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ABSTRACT
The 50 cap of human messenger RNA consists of
an inverted 7-methylguanosine linked to the first
transcribed nucleotide by a unique 50–50 triphosphate
bond followed by 20-O-ribose methylation of the
first and often the second transcribed nucleotides,
likely serving to modify efficiency of transcript
processing, translation and stability. We report the
validation of a human enzyme that methylates
the ribose of the second transcribed nucleotide
encoded by FTSJD1, henceforth renamed HMTR2
to reflect function. Purified recombinant hMTr2
protein transfers a methyl group from S-adenosyl-
methionine to the 20-O-ribose of the second nucleo-
tide of messenger RNA and small nuclear RNA.
Neither N
7 methylation of the guanosine cap nor
20-O-ribose methylation of the first transcribed
nucleotide are required for hMTr2, but the presence
of cap1 methylation increases hMTr2 activity. The
hMTr2 protein is distributed throughout the nucleus
and cytosol, in contrast to the nuclear hMTr1. The
details of how and why specific transcripts undergo
modification with these ribose methylations remains
to be elucidated. The 20-O-ribose RNA cap methyl-
transferases are present in varying combinations in
most eukaryotic and many viral genomes. With the
capping enzymes in hand their biological purpose
can be ascertained.
INTRODUCTION
The messenger RNAs (mRNAs) of all metazoan organ-
isms and most eukaryotic viruses possess a 50 cap structure
consisting of a 7-methyl guanosine (m
7G) linked via an
inverted 50–50 triphosphate bridge to the initiating nucleo-
side of the transcript (1–3), which is itself modiﬁed by 20-
O-ribose methylation at the ﬁrst and often the second
transcribed nucleotides. The inverted m
7G or cap0 struc-
ture marks transcription start sites, and has multiple
effects on gene expression, including enhancement of
RNA stability, splicing, nucleocytoplasmic transport and
translation initiation, as facilitated by interactions with
nuclear and cytoplasmic cap binding proteins (4–8).
Cap0 is present on all eukaryotic mRNAs and is essen-
tial for cell growth of Saccharomyces cerevisiae (9,10) and
survival of mammalian cells (8,11). The m
7G capping is
the earliest mRNA processing event, occurring cotrans-
criptionally on nascent chains synthesized by RNA poly-
merase II (12,13). A series of enzymatic reactions are
required for cap0 formation, in which the 50-triphosphate
terminus of a nascent pre-mRNA is hydrolyzed to a di-
phosphate by RNA triphosphatase (Enzyme Commission
number 3.1.3.33), the diphosphate RNA end is capped
with GMP by RNA guanylyltransferase (GTase) (E.C.
2.7.7.50) to yield a GpppNpNp- structure, here referred
to as ‘capG’, and ﬁnally capG is methylated by RNA
(guanine-N
7) methyltransferase (MTase) (EC 2.1.1.56) to
yield a cap0 structure. The three enzymatic activities are
found encoded by independent peptides or fused in bi- or
tri-functional multidomain proteins [reviews: (14,15)].
In humans, the small nuclear (sn) RNAs involved in
*To whom correspondence should be addressed. Tel: +48 22 597 0750; Fax: +48 22 597 0715; Email: iamb@genesilico.pl
Present addresses:
Bidyottam Mittra, Department of Cell Biology & Molecular Genetics, University of Maryland, College Park, MD, 20742, USA.
Jesse R. Zamudio, Koch Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
4756–4768 Nucleic Acids Research, 2011, Vol. 39, No. 11 Published online 9 February 2011
doi:10.1093/nar/gkr038
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.splicing receive cotranscriptional cap0 as well and continue
their 50-end maturation with hypermethylation of m
7G
to m
2,2,7G (trimethylguanosine or TMG). The capTMG
structure is formed in the cytoplasm by trimethylguano-
sine synthase 1 (Tgs1) (16,17). TMG formation, particular-
ly in U1 snRNA, is required for proper snRNA
trafﬁcking and thus for efﬁcient pre-mRNA splicing (18).
The U6 snRNA is the exception, as this RNA polymerase
III-derived transcript carries a g methyl triphosphate
cap (19).
In higher eukaryotes, including insects, vertebrates and
their viruses, mRNA and snRNA 50-ends are modiﬁed
by the addition of methyl groups to the ﬁrst and/or the
second transcribed nucleotides [reviewed in (20)].
Methylation of the ribose on the ﬁrst transcribed nucleo-
tide is termed cap1 and similar methylation of the second
transcribed position is termed cap2. Thirty years ago, the
human cap1 and cap2 MTases (hMTr1 and hMTr2,
respectively) were detected and enriched in fractionated
HeLa cell extracts (21). These activities were found
predominantly in the nucleus and cytoplasm, respectively.
In humans, cap0 and cap1 methylations are present on all
mRNA molecules, while about half of the capped poly(A)
molecules contain a 20-O-ribose methylated residue on
the second transcribed nucleotide (22). The U1, U2, U4
and U5 snRNAs are methylated at the two ﬁrst positions
(23). Cap1 and cap2 methylations in U2 snRNA are
required for spliceosomal E-complex formation and, as a
consequence, for efﬁcient pre-mRNA splicing (24). Some
eukaryotic organisms, such as the kinetoplastids possess a
more elaborate mRNA cap structure, with additional cap3
and cap4 methylations of riboses and additional methy-
lations of the ﬁrst and fourth base (25,26). Complete
methylation on the ﬁrst four nucleotides is not required
for viability of Trypanosoma brucei (27,28); however,
reduced methylation results in lower rates of translation
(29). For clarity in this study, a cap methylated on both
the 0 and 1 positions (m
7GpppN1m) is referred to as cap01,
and a cap methylated on the inverted guanosine and
the ﬁrst two riboses (m
7GpppN1mN2m) is cap012; cap1
and cap2 are reserved for structures with the GpppN1N2
cap modiﬁed only on N1 or N2, respectively, without
other modiﬁcations, in particular the m
7G methylation.
With the extensive cap1 and cap2 methylation per-
formed by the host enzymatic activities, the maintenance
of 20-O-ribose MTases in many viral genomes is suggestive
of a vital role in gene expression. Cytosolic transcription,
as used by pox viruses or RNA polymerase speciﬁcities
that prevent interaction of the nuclear host cap1 MTase
may explain the necessity for an independent enzyme.
Alternative scenarios, such as the appropriation of host
cap structures by inﬂuenza virus (30), tell the same story:
the 20-O-ribose methylations are required, if not for basic
viability, for efﬁcient translation among a capped tran-
script population, without which the virus faces competi-
tive elimination. Regardless of their current genomic
location, these enzymes are related, a predicted conse-
quence of horizontal gene transfer events between the
host and invading virus. Cap2 and cap3-speciﬁc MTases
in trypanosomes are related to the poxvirus cap1 MTase
(27), while the cap1 MTase in trypanosomes is related to
the cap1-speciﬁc enzyme from nucleopolyhedroviruses
(26). The viral or cellular origin of cap methylation is
unclear, as is that of the cap-speciﬁc 20-O-ribose MTases
in different eukaryotic cells.
Sequence analysis of ribose MTases lead to identiﬁca-
tion of two paralogous human genes KIAA0082 and
FLJ11171 (also known as FTSJD2 and FTSJD1) (31).
In the course of our work on experimental validation of
those results, cap1 activity of FTSJD2 was shown by
another group (32). Here, we demonstrate the cap2
activity of FTSJD1 and validate FTSJD2 as the hMTr1.
The hMTr2 protein is found throughout the cell, in
contrast to hMTr1, which is present only in the nucleus.
Both can modify substrates with the GpppN (capG) struc-
ture. Neither enzyme requires absolutely the presence of
other methylations; however, the presence of cap1 modi-
ﬁcation increases the efﬁciency of cap2 modiﬁcation.
Comparative analysis of human cap1 and cap2 MTases
and their homologs sheds light on their common origin
and relationship to other cap-modifying enzymes.
MATERIALS AND METHODS
Cloning of hMTr1 and hMTr2
The cDNAs of the HMTR1 (a.k.a. KIAA0082, ISG95,
FTSJD2) and HMTR2 (a.k.a. AFT, FLJ11171, FTSJD1)
open reading frames were purchased from imaGenes
GmbH (IMAGE ID 4944457 and 5267637) and ampliﬁed
by PCR using oligonucleotides that introduce restriction
sites compatible with the cloning sites of the indicated
plasmids. To direct the synthesis of proteins with a
FLAG-tag at the N-terminus, a NotI restriction site was
introduced 50 of the predicted translation start site and an
XbaI site 30 of the stop codon. PCR products were
digested accordingly and inserted into p3xFLAG-
CMV-10 Expression Vector (Sigma), leading to plasmids
p3xFLAG-CMV-10-hMTr1 and p3xFLAG-CMV-10-
hMTr2. The p3xFLAG-CMV-7-BAP control plasmid
with the sequence of Escherichia coli bacterial alkaline
phosphatase (BAP) with FLAG-tag was purchased from
Sigma. For the cellular localization assay, HMTR1 and
HMTR2 open reading frames were inserted into the
GW1 plasmid (kind gift from Dr Morgan Sheng), with
the use of KpnI and SalI for HMTR1, and BglI and
SalI for HMTR2, to direct the expression of proteins
with myc-tag.
Mutant variants of these genes were constructed by
PCR. The residues targeted for alanine substitution
included K239, D364 and K404 for the hMTr1 protein
and K117, D235 and K275 for hMTr2. The construction
for expression of the N-terminal part of hMTr2 was
prepared by inserting a stop codon after 530 or 430
amino acid. The mutated genes were sequenced and
found to contain only the desired changes. Sequences of
all primers used in this study are listed in Supplementary
Table S1.
Eukaryotic overexpression of hMTr1, hMTr2 and BAP
HEK 293T cells were cultured in Dulbecco’s Modiﬁed
Eagle Medium (DMEM, Invitrogen) supplemented with
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(2mM), penicillin (100U/ml) and streptomycin (100mg/
ml). For immunoafﬁnity puriﬁcations HEK 293T cells
were grown to 50–60% conﬂuency and transfected with
8mg of p3xFLAG-CMV-10-hMTr1, p3xFLAG-CMV-10-
hMTr2 or p3xFLAG-CMV-7-BAP vector per 100mm
dish using jetPEI (Polyplus Transfection) transfection
reagent according to manufacturer instructions. After
40h cells were harvested and frozen in liquid nitrogen
for storage at  76 C. Cells from a 100mm dish were re-
suspended in lysis buffer [50 mM Tris–HCl, pH 7.4,
150mM NaCl, 1mM EDTA, 0.5% Triton X-100,
Protease Inhibitor Cocktail for use with mammalian cell
and tissue extracts (Sigma)], disrupted on ice with a Pellet
pestle (Sigma) and incubated for 1h at 4 C. The lysate
was centrifuged for 30min at 20000g. Supernatant
was incubated with 25ml ANTI-FLAG M2 Afﬁnity Gel
(Sigma) with rotation overnight at 4 C. Beads were
washed following manufacturer recommendations and re-
suspended in activity assay buffer. FLAG fusion proteins
were used to test enzymatic activity in MTase assays. The
process of puriﬁcation was monitored by western blot
using monoclonal ANTI-FLAG M2 antibody produced
in mouse (Sigma) and Anti-Mouse IgG Peroxidase
Conjugate (Sigma). Additionally, the identity of hMTr1
was conﬁrmed with anti-FTSJD2 antibody produced
in rabbit (Novus Biologicals) and anti-rabbit IgG–
peroxidase (Sigma) (data not shown).
Cloning, bacterial expression and puriﬁcation of
TbMTr2 and "Tgs1
The TbMTr2 open reading frame encoding the cap2
MTase from T. brucei was cloned into the pET28a
vector (Novagen) to direct the expression of a His-
tagged protein (27). For protein overexpression, the plas-
mid was transformed into E. coli BL21 (DE3) (Novagen).
A recombinant TbMTr2 protein was obtained from
cultures grown overnight at 24 C in the presence of 2%
ethanol and 0.1mM isopropyl-b-D-galactopyranoside
(IPTG). The cDNA encoding a fragment of the Tgs1
enzyme (amino acid residues 574–853) was purchased
from imaGenes GmbH (IMAGE ID 4513665) and the
catalytically active portion of Tgs1 (residues 631–853)
(33) was inserted into the pET41 vector to produce a
His-tagged fusion protein with an N-terminal GST tag.
The resulting plasmid pET41- Tgs1 was transformed
into E. coli BL21 (DE3) and the protein was obtained
from cultures grown at 18 C in the presence of 2%
ethanol and 0.2mM IPTG for 20h. Recombinant
proteins were puriﬁed by Ni-column chromatography
with His-Select Nickel Afﬁnity Gel (Sigma) and eluted
with 25mM HEPES (pH 8), 300mM NaCl, 10mM
2-mercaptoethanol, 10% glycerol and a gradient of imid-
azole ranging from 10 to 250mM.
RNA substrate preparation
Double-stranded DNA oligonucleotides containing the T7
promoter and the sequence of desired RNA transcripts
with sticky ends compatible with NcoI and XhoI were
cloned into appropriately digested pTZ19R vector
(Fermentas). For transcription of RNA starting with
adenine, a T7 bacteriophage class II ø2.5 promoter (34)
was used. pTZ19R-RNA vectors were digested with XhoI
and gel puriﬁed. Three micrograms of linearized plasmid
were used as template for in vitro transcription using
the T7 Megashortscript Kit (Ambion). Subsequently,
the reaction mixture was treated with 2 U RNase-free
DNase I for 30min at 37 C to remove the template
DNA. RNA was puriﬁed by phenol/chloroform extrac-
tion and ethanol precipitation. Two variant RNA mol-
ecules of 63nt were produced: RNA-GG that starts with
guanosine (pppGpGpGpX) and RNA-AG that starts with
adenine (pppApGpGpX) were X=TAACGCTATTATT
ACAAAGCTCTTTTATGTAGTGTGCGTACCACGG
TAGCAGGTACTGCG, based on the T. brucei spliced
leader RNA gene (GenBank # Z50171.1), chosen for
convenience. RNA molecules were subjected to capping
reactions using vaccinia virus capping enzyme (VCE)
and vaccinia virus Cap1 MTase (VMT) ScriptCap
(Epicentre; Supplementary Figure S1A). Reactions were
carried out following the manufacturer recommendations
with addition of 10mCi [a-
32P] GTP (3000Ci/mmol;
Hartman Analytic GmbH), with or without methyl
donor S-adenosylmethionine (SAM) to form m
7GpppN-
(cap0) and GpppN- (capG) structures, respectively. The
nomenclature used throughout this manuscript is
summarized in Table 1. The ScriptCap 20-O-MTase was
used to create the m
7GpppNm-(cap01) and GpppNm-
(capG1) structures. Following the reaction,
32P-labeled
capped RNA molecules were puriﬁed by extraction with
phenol/chloroform, passed through mini Quick Spin Oligo
Columns (Roche) to remove free radionucleotides and
precipitated with ethanol.
For generating internally,
32P-labeled G-capped tran-
script RNA-GA [GpppGp*ApGp(TpCp)12], transcription
was carried out using pTZ19R-RNA-GA template,
prepared as described above, with the addition of 10mCi
of [a-
32P] ATP (3000Ci/mmol; Hartman Analytic GmbH)
and the GpppG cap analog (Epicentre) following the
manufacturer instructions. After the removal of template
DNA, RNA transcripts were gel puriﬁed. Subsequently,
viral enzymes were used to form molecules containing
cap0 or cap01 (Supplementary Figure S1B).
Templates for in vitro transcription of U1 and U2
snRNAs were prepared by a PCR-based method using
Table 1. The nomenclature of cap structure variants used throughout
this manuscript
capG GpppNpNp-
capG1 GpppNmpNp-
capG2 GpppNpNmp-
capG12 GpppNmpNmp-
cap0 m
7GpppNpNp-
cap01 m
7GpppNmpNp-
cap02 m
7GpppNpNmp-
cap012 m
7GpppNmpNmp-
capTMG m
7,2,2GpppNpNp-
capTMG1 m
7,2,2GpppNmpNp-
capTMG2 m
7,2,2GpppNpNmp-
capTMG12 m
7,2,2GpppNmpNmp-
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primers that introduce the T7 bacteriophage class II ø2.5
promoter upstream of a desired sequence. Gel-puriﬁed
PCR products (0.5mg) were used for in vitro transcrip-
tion using the T7 Megashortscript Kit. TMG-capped
RNA was prepared in vitro by m
7G cap modiﬁcation
to m
2,2,7G by the active part (residues 631–853) of the
Tgs1 enzyme (33). Reactions were carried out in 50mM
Tris–HCl (pH 8), 5mM dithiothreitol (DTT), 100mM
SAM, 10U Ribolock (Fermentas), 1mg protein and
2pmol RNA with different forms of
32P-labeled cap
structures for 30min at 37 C. Subsequently, RNA was
puriﬁed by phenol/chloroform extraction and ethanol
precipitation.
Methyltransferase assays
Methylation reactions with hMTr2 were carried out in
30mM Tris–HCl (pH 7.4), 50mM KCl, 1mM EDTA,
10mM DTT, 100mM SAM, 10U Ribolock, puriﬁed
enzyme and 2pmol substrate RNA in a total volume of
20ml. The reaction buffer for hMTr1 differed in pH (8.4)
and KCl concentration (150mM) and the other compo-
nents remained the same. Reactions were carried out for
1h at 37 C. BAP protein was used as a negative control.
For hMTr1, the VMT enzyme from the ScriptCap kit was
used as a positive control. Methylation with VMT was
performed following manufacturer recommendations.
For hMTr2, the trypanosome enzyme TbMTr2 was used
as a positive control. Methylation with TbMTr2 was
carried out in 50mM Tris–HCl (pH 7.4), 5mM DTT,
100mM SAM, 10U Ribolock, 2pmol
32P-labeled cap
structure RNA and 4pmol enzyme for 30min at 27 C.
The modiﬁed RNA was puriﬁed by phenol/chloroform
extraction and ethanol precipitation. The RNA was
digested with either 2U nuclease P1 (Sigma) in 10mM
Tris–HCl (pH 7.5), 10mM MgCl2 and 50mM NaCl, or
with 2.5U RNase T2 (MoBiTec GmbH) in 50mM
ammonium acetate (pH 4.5) overnight at 37 C. The diges-
tion products were resolved on a 21% polyacrylamide/8M
urea gel and visualized by PhosphorImaging (Storm 820,
Amersham Bioscience).
Internally labeled RNAs were digested with nuclease
P1 as described above. Digested samples were spotted
on the cellulose-coated thin layer chromatography plates
(Merck), together with unlabeled 50-monophosphate ribo-
nucleosides: G, A, U, C, Am and m
6A and developed in
isobutyric acid:H2O:ammonium hydroxide (66:33:1; v:v:v)
as the ﬁrst-dimension solvent and isopropanol/
concentrated HCl/water (68:18:14; v:v:v) as the second-
dimension solvent. Detection and identiﬁcation of the
radiolabeled
32P-modiﬁed nucleotides in RNA digestions
was performed by comparing the autoradiograph with UV
pattern and reference maps established in the two TLC
systems.
Immunolocalization
MCF-7 cells were cultured in Dulbecco’s Modiﬁed Eagle
Medium (DMEM, Invitrogen) supplemented with 10%
fetal calf serum (FCS, Invitrogen), glutamine (2mM),
penicillin (100U/ml) and streptomycin (100mg/ml) and
grown on 10mm glass coverslips in 24-well plates to
60% conﬂuency and transfected with 0.6mg of GW1-
myc-hMTr1, GW1-myc-hMTr2 or a control plasmid
EGFP-C1 (Clontech) with the use of Lipofectamine 2000
(Invitrogen). After 24h, cells were ﬁxed and stained with
mouse anti-myc (9E10 from Calbiochem) or rabbit anti-
GFP antibodies (MBL) to visualize the recombinant
protein. Hoechst 33258 (Sigma) and phalloidin 568
(Invitrogen) were used to visualize cell nuclei and
F-actin (cell shape), respectively. Images of the cells were
acquired with a LSM510 Exciter confocal microscope as a
Z-stack of single plane images with a 63 objective.
Bioinformatic analyses
Searches of the current version of the non-redundant
protein sequence database (nr) were carried out with
PSI-BLAST (35) using full-length sequences of hMTr1
and hMTr2 as queries. In order to identify subfamilies
of the related sequences and to visualize sequence similari-
ties, we chose the clustering tool CLANS (Cluster
ANalysis of Sequences), which uses the P-values of high-
scoring segment pairs (HSPs) obtained from the N N
BLAST search, to compute attractive and repulsive
forces between each sequence pair and to move the se-
quences according to the force vectors resulting from all
pair-wise interactions (36). The clusters of closest
homologs of hMTr1 and hMTr2 were extracted. Global
multiple sequence alignments were calculated for individ-
ual families using MAFFT (37) and adjusted manually to
maximize the number of aligned homologous residues and
preserve the continuity of predicted secondary structure
elements. Incomplete sequences were discarded if the
deletion spanned >30% of the alignment, or repaired
using amino acid sequences predicted from the available
DNA sequences of the corresponding genes.
For phylogenetic analyses, we constructed a multiple
sequence alignment composed of the catalytic domains
of MTases from different families, guided by superimpos-
ition of representative crystal structures or theoretical
models. Structure prediction for hMTr1 and hMTr2
was carried out by the GeneSilico metaserver (38), which
serves as a broker providing a comprehensive view of the
results collected from various protein fold recognition
methods along with the prediction of the secondary struc-
ture, protein order/disorder, solvent accessibility, poten-
tial RNA/DNA binding sites, etc. Phylogenetic trees
were calculated with MEGA 4.0 (39) using the minimum
evolution method with the JTT model of substitutions and
pair-wise deletions. The initial tree was calculated by the
NJ method, with the Closest Neighbor Search option set
to level=2. To assess conﬁdence for each node of the
phylogenetic tree, the bootstrap test was performed with
1000 replications.
RESULTS
Sequence analyses of hMTr1 and hMTr2 candidates
FTSJD1 and FTSJD2 were identiﬁed as candidates for
human RNA 20-O-ribose MTases based on the presence
of a domain homologous to known bacterial and
Nucleic Acids Research, 2011,Vol.39, No. 11 4759eukaryotic tRNA and rRNA MTases (31). FTSJD2 pos-
sessed an additional domain homologous to the GTase
domain present in mRNA capping enzymes, which
prompted us to consider both proteins as candidates for
RNA cap MTases. Sequence database searches initiated
with FTSJD1 and FTSJD2 yielded numerous members of
the Rossmann-fold MTase (RFM) family. Sequence clus-
tering (see ‘Materials and Methods’ section) revealed that
FTSJD1 and FTSJD2 are related paralogs that form an
isolated family together with a number of proteins from
higher eukaryotes and eukaryotic viruses (Supplementary
Figure S2). In particular, the previously characterized
cap1 MTases from Autographa californica nucleopoly-
hedrovirus (AcNPV) (40) and T. brucei (26,41) grouped
with FTSJD2, making it the primary hMTr1 candidate.
Structure prediction in combination with multiple
sequence alignment analysis (data not shown) conﬁrmed
that FTSJD2, the putative hMTr1, carried a putative
nuclear localization signal (NLS), a G-patch domain
potentially involved in RNA binding, an RFM domain
with a conserved K-D-K triad characteristic for 20-O-
ribose MTases, a GTase-like domain lacking catalytic
residues (26,42) and a WW domain potentially involved
in protein–protein interactions. FTSJD1, the candidate
hMTr2, was composed of two RFM domains (Figure 1).
A multiple sequence alignment of hMTr2 orthologs
(Supplementary Figure S3) revealed that the N-terminal
RFM domain had a conserved SAM-binding site (motifs
I–III). Interestingly, in motif I the Asp residue present
in other 20-O-ribose MTases was replaced by His, but it
reappeared elsewhere, shifted three positions toward the
C-terminus. As in hMTr1, the N-terminal RFM domain
of hMTr2 contained a characteristic catalytic K-D-K
triad. These residues were conserved in all members
of this family, with the exception of proteins from
Plasmodium, where they were replaced by the variant
Y-(N/D)-K. Members of Plasmodium also exhibited dele-
tions of one residue in motif I, and lost the otherwise
universally conserved E residue in motif VIII, whose coun-
terpart in RrmJ (E199) plays a minor role in the MTase
activity (43). The C-terminal RFM domain was present in
all members of the hMTr2 family, with the exception of
two viral and one algal proteins, and was more variable
than the N-terminal domain. Despite the overall
homology to enzymatically active RFM domains, this
domain lacked conserved residues required to bind SAM
as motifs I–III were practically undetectable, and neither
the K-D-K triad nor any other obvious candidates for an
active site were identiﬁed.
Recombinant FTSJD2 and FTSJD1 exhibit cap1- and
cap2-MTase activities
To test the cap2-MTase activity of our candidate hMTr2,
in vitro transcribed RNA-GG was capped with VCE in
the presence of [a-
32P] GTP and modiﬁed with VMT
to form a cap01 substrate (Supplementary Figure S1,
Table S1). This cap01-RNA was subjected to methylation
with the puriﬁed FLAG-tagged recombinant hMTr2
protein, followed by RNase T2 digestion to generate
30-monophosphate nucleotides. Presence of the 20-O-
ribose methylation prevents hydrolysis by RNase T2
generating RNA fragments of longer length (44).
Digestion products were resolved on a polyacrylamide
gel, along with control samples generated by the tryp-
anosome cap2-MTase TbMTr2 as a positive control,
and immunopuriﬁed FLAG-tagged BAP protein as a
negative control (Figure 2A). When cap01-RNA was
treated with hMTr2, a radioactive RNA fragment that
comigrated with a RNase T2-resistant fragment from a
sample treated with TbMTr2 was detected (Figure 2A,
lanes 2 and 3), albeit at lower efﬁciency, corresponding
to the predicted cap012 product. No methyl incorporation
was observed in a control reaction with a puriﬁed BAP
protein (Figure 2A, lane 4), demonstrating that the cap2
MTase activity was speciﬁcally from overexpressed
hMTr2. Analogous experiments performed with the
RNA-AG substrate also yielded a methylation product
(data not shown).
In order to conﬁrm the 20-O-ribose MTase speciﬁcity of
the candidate hMTr2, we identiﬁed the radiolabeled
32P-modiﬁed nucleotides in RNA digests by two-
dimensional thin layer chromatography (2D-TLC). The
RNA-GA substrate used in this experiment was
prepared by in vitro transcription with [a-
32P] ATP and
addition of the cap analog (GpppG), followed by methy-
lation with VCE and VMT to create cap01-RNA
(Supplementary Figure S1B). Digestion of the substrate
RNA with nuclease P1, followed by 2D-TLC analysis,
resulted in a single radiolabeled spot corresponding to
pA (Figure 2B). Incubation of the substrate RNA-GA
with recombinant hMTr2 in the presence of SAM
yielded a new radiolabeled spot that comigrated with
Figure 1. Domain architecture of hMTr1 and hMTr2 proteins. Domain boundaries were predicted according to protein fold recognition analyses
carried out via the GeneSilico metaserver (38). Amino acid residues important for the MTase activity are indicated.
4760 Nucleic Acids Research, 2011,Vol.39, No. 11pAm marker (Figure 2C) and was resolved clearly from
the 50-monophosphate m
6A marker that migrates to close
position on a published 2D map of methylated
50-phosphonucleosides (44). The weak signal of pAm
may have resulted from the low efﬁciency of capG forma-
tion, as only a subset of labeled RNA molecules that had
GpppG incorporated during transcription were a sub-
strate for hMTr2 (see below), and from inefﬁcient methy-
lation by VMT and hMTr2. For the same experiment,
we also run RNase T2/PAGE analysis and found that
the efﬁciency of methylation seen on gel matches that
seen on TLC (Supplementary Figure S4). With conﬁrm-
ation of the FTSJD1 gene product methylation of the
20-hydroxyl on the second nucleotide, this protein was
henceforth referred to as hMTr2. In parallel, 2D-TLC
analysis were done for uncapped (pppG-ended), [a-
32P]
ATP-labeled RNA-GA that was incubated with
recombinant hMTr2 in the presence of SAM. Only one
spot that corresponds to unmodiﬁed pA was detected
(Supplementary Figure S5) demonstrating that the
hMTr2 MTase activity is dependent on the presence of
capG.
Analogous experiments to test cap1 MTase activity of
the HMTR1 gene product were performed. This protein
methylated the ﬁrst transcribed nucleotide (Supplementary
F i g u r eS 6 )i na c c o r dw i t hp a r a l l e ls t u d i e s( 3 2 ) .F o ra c t i v i t y
tests, we used RNA-GG and RNA-AG substrates and
found that hMTr1 transfers a m e t h y lg r o u pt oG( 3 2 ) ,a s
well as A residues at position 1 with similar effectiveness
(data not shown). The precise position of the methyl
group addition was analyzed using internally [a-
32P]
ATP-labeled RNA-GA substrate by 2D-TLC, and con-
ﬁrmed methylation at 20-O-ribose position of the ﬁrst
transcribed nucleotide (Supplementary Figure S6).
Figure 2. hMTr2 activity and substrate requirements. Methyltransferase activity: In vitro transcribed RNA-GG molecules with the
32P-labeled cap01
structure (A) were incubated with enzymes as indicated in the presence of SAM. Puriﬁed product RNA was digested with RNase T2. Digestion
products were resolved on 21% polyacrylamide/8M urea gel and visualized by autoradiography. BAP protein was used as negative control. RNA
with
32P-labeled cap structure created with the TbMTr2 enzyme was used as a reference. Speciﬁcity: autoradiography of two-dimensional chro-
matograms of 50-phosphate nucleosides on thin layer cellulose plates. [a-
32P] ATP-labeled in vitro transcribed cap01-RNA-GA was incubated with
SAM in the absence, (B) or presence (C) of the hMTr2 protein. Product RNA was puriﬁed, cleaved by nuclease P1 and the resulting nucleotides were
analyzed as described (44). 50-monophosphate ribonucleosides of G, A, U, C, Am and m
6A were used as standards. Substrate requirements: In vitro
transcribed RNA-GG molecules with
32P-labeled cap0 (D) or capG (E) structure were incubated with one of the indicated enzymes, added in a given
order, in the presence of SAM. After every modiﬁcation step RNA molecules were puriﬁed by phenol/chloroform extraction and ethanol precipi-
tation. Final products were digested and analyzed as described in legend for panel A. Asterisks indicate positions of
32P-labeled phosphates.
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methylations
To broaden our knowledge about the substrate requirements
of hMTr2, the methylation assay was performed using
32P-labeled capG1 that lacked the methylation on the
50-inverted G and cap01-RNA-GG substrates (Figure 2,
panels D and E). After RNase T2 digestion, an additional
band was observed with both substrates (Figure 2D and E,
lanes 4 and 5). Interestingly, while the trypanosome cap2-
MTase activity was dependent on cap0, the hMTr2
recognized RNA with either cap0 or capG structures.
This result indicated that the N
7-methylation of the
guanosine cap was not required for the cap2 modiﬁcation.
The association of hMTr1 with RNA polymerase II
in vivo (42) indicates that cap1 formation occurs early in
the synthesis of nascent mRNA. As such, hMTr1 may not
recognize cap02 substrates, while hMTr2 may display a
preference for cap01 transcripts. To examine activities
on differentially methylated substrates, the in vitro
MTase assay was performed on 50-end labeled capG and
cap0-RNA-GG substrates using sequential enzymatic
combinations, each performed in isolation (Figure 2D
and E). hMTr1 catalyzed methylations on both cap0
(Figure 2D, lane 3) and cap02 (Figure 2D, lane 8).
hMTr2 methylates both cap0 (Figure 2D, lanes 7 and 8)
and cap01 (Figure 2D, lanes 4 and 5) substrates with
better efﬁciency for cap01. The human enzymes displayed
low relative efﬁciencies as compared with the VMT
and TbMTr2 controls. The hMTr2 treatment alone did
not yield a speciﬁc product after RNase T2 digestion
(Figure 2D, lane 6), as the absence of the cap1 methylation
resulted in separation of the label from the modiﬁed nu-
cleotide; the secondary 20-O-ribose methylation of
position 1 by hMTr1 or VMT allowed detection of the
primary cap2 modiﬁcations by hMTr2 or TbMTr2. The
same regimen applied to the capG substrate yielded
similar results, at reduced efﬁciency for hMTr2, with the
exception of the TbMTr2 control, which did not recognize
the capG substrate (Figure 2E, lane 9). Although neither
hMTase may see this variety in vivo, the enzymes possess
the capability to recognize a relatively broad array of
substrates, with preferential activity suggesting a 50 to 30
maturation pathway.
The hMTr2 requires both RFM domains
To verify the predicted K-D-K-active sites of the hMTr1
and hMTr2 enzymes, site-directed mutagenesis was
performed to generate protein variants with individual
residues substituted by alanine. In vitro transcribed
RNA-GG with
32P-labeled cap0 or cap01 structures
were incubated with the puriﬁed protein variants in the
presence of SAM. The reaction products were digested
with nuclease P1 or RNase T2 and separated on a poly-
acrylamide gel. None of the variants exhibited MTase
activity (Figure 3), indicating that each residue of the
K-D-K triad is essential for the activity of both hMTr1
(Figure 3A, lanes 4–6) and hMTr2 (Figure 3B, lanes 3–5).
Region 431–530 of hMTr2 is highly divergent, we
predict that it corresponds to a degenerated SAM-
binding site of the C-terminal domain, but we cannot
completely exclude that it contains a linker between
domains or an extension of the N-terminal domain.
Therefore, we checked the activity of two truncated
variants of hMTr2: 1–430 that contained just the
conserved N-terminal RFM domain, and 1–530 that add-
itionally included the diverged region, but lacked the
conserved core of the C-terminal RFM domain found in
the 531–770 region.
Both C-terminal deletion variants 1–530 and 1–430 were
tested for the hMTr2 activity and found to be inactive
(Figure 3B, lanes 6 and 7). Thus, the C-terminal
MTase-like domain is essential for hMTr2 activity,
despite the absence of a conserved MTase active site.
The hMTr1 and hMTr2 recognize TMG-capped snRNAs
in vitro
Both hMTr1 and hMTr2 were assayed on in vitro-
transcribed U1 and U2 snRNAs, the endogenous RNA
molecules known to possess TMG, cap1 and cap2 modi-
ﬁcations (capTMG12). In trypanosomes, an intriguing
sequence speciﬁcity was found for TbMTr1 cap1 MTase,
functionally limiting activity of the enzyme to the spliced
leader RNA and the cap0 form of the U1 snRNA (26,41).
In vitro-transcribed human U1 and U2 snRNAs with
32P-labeled cap0 or cap01 structures representing precur-
sor forms of the mature products were used for hMTr1
(Figure 4A) or hMTr2 (Figure 4B) activity assays. The U1
and U2 snRNA substrates initiate with AUA and AUG,
respectively. Both hMTr1 and hMTr2 methylated the
snRNA substrates in vitro. The hMTr1 effectively
methylated RNA in that sequence context (Figure 4A,
lanes 3 and 6). In contrast, hMTr2 converted approxi-
mately half of the cap01 starting material to cap012
(Figure 4B, lanes 3 and 6) as compared with the efﬁcient
conversion of the substrate by the equivalent TbMTr2
trypanosome version of the enzyme (Figure 4B, lanes 2
and 5). The reason for this difference remains to be
explained.
The relative efﬁciencies of speciﬁc orders of methylation
events and the effects of the presence of a methyl group at
additional cap0 positions were examined. To this end,
capping reactions were performed with Tgs1, hMTr1
(Figure 4C) and hMTr2 (Figure 4D) on in vitro-
transcribed U2 snRNA molecules with
32P-labeled cap0
or cap01 structures, respectively. The reactions differed
in the order of action of capping enzymes, as indicated
above the panels. Both hMTr1 and hMTr2 methylated
RNA with the capTMG structure (Figure 4C, lane 5;
Figure 4D, lane 3). Likewise, Tgs1 can act on RNA with
methyl groups on both riboses of the ﬁrst two nucleotides
(Figure 4D, lanes 5 and 6) as well as on cap0 RNA
(Figure 4C, lane 2). Thus, no preference was seen for
any speciﬁc order of action among these enzymes.
hMTr1 and hMTr2 could be responsible for snRNA
20-O-ribose methylations in vivo.
The hMTr2 has a signiﬁcant nuclear presence
Cellular localization of hMTr2 was assayed in situ by
immunostaining of epitope-tagged protein. MCF7 cells
were transfected with GW1-myc-hMTr2 or control
4762 Nucleic Acids Research, 2011,Vol.39, No. 11plasmid EGFP-C1 that distributed throughout the cell. In
parallel, hMTr1 was examined using GW1-myc-hMTr1.
Twenty-four hours post-transfection, cells were ﬁxed
and immunostained for the overexpressed protein.
The myc-hMTr2 was present in both the cytoplasm and
the nucleus (Figure 5). Veriﬁcation of labeling was done
by checking the orthogonal axis views (Figure 5B). The
unit volume ratio of myc-hMTr2 signal in the nucleoplasm
Figure 4. hMTr1 and hMTr2 act on the U1 and U2 snRNAs in vitro. In vitro transcribed U1 and U2 snRNA molecules with
32P-labeled cap0 (A
and C) or cap01 (B and D) structures were incubated with one of the indicated enzymes, added in the order indicated and SAM. After every
modiﬁcation step RNA was puriﬁed by phenol/chloroform extraction and ethanol precipitation. Final products were fragmented with nuclease P1 (A
and C) or RNase T2 (B and D). Digestion products were resolved on 21% polyacrylamide/8M urea gels and visualized by autoradiography. Cap
structures modiﬁed with VMT (A and C) or TbMTr2 (B and D) were used as positive controls. Asterisks indicate positions of
32P-labeled
phosphates.
Figure 3. Analysis of hMTr1 and hMTr2 mutants. In vitro transcribed RNA-GG molecules with
32P-labeled cap0 (A) or cap01 (B) structures were
incubated with indicated enzymes [wild-type (hMTr1, hMTr2), alanine-substituted variants of hMTr1 (K239A, D365A, K404A) and hMTr2 (K117A,
D235A, K275A) or truncated forms of hMTr2 (1–530, 1–430)] in the presence of SAM. Puriﬁed product RNA was digested with nuclease P1 (A)o r
RNase T2 (B). Digestion products were resolved on a 21% polyacrylamide/8M urea gel and visualized by autoradiography. Asterisks indicate
positions of
32P-labeled phosphates.
Nucleic Acids Research, 2011,Vol.39, No. 11 4763versus cytosol was 1.25, comparable with the 1.45 ratio
detected in cells expressing EGFP that was spread by
passive diffusion. The myc-hMTr1 was conﬁned to the
nucleus (32,42) with almost no signal detectable in the
cytosol. Both myc-hMTr1 and myc-hMTr2 were
excluded from DNA-free nuclear bodies that are likely
to represent nucleoli. Thus RNAs probably acquire the
cap1 modiﬁcation by hMTr1 during or shortly after tran-
scription in the nucleus, followed by hMTr2 capping in
either nucleus or after export to the cytoplasm. The
mRNA and snRNAs may both serve as substrates for
these enzymes, but their presentation may differ along
with their divergent paths after acquisition of cap2.
Evolution of cap MTases hints at additional cap variants
The identiﬁcation of genes-encoding human cap MTases
provided an opportunity to study their evolutionary
origin. A multiple alignment of the catalytic RFM
domain from cap 20-O-ribose MTases, from humans and
other species (e.g. trypanosomes and viruses), and their
orthologs was constructed (Supplementary Figure S7).
The family of RrmJ MTases present in the last universal
common ancestor of all extant organisms was used as an
outgroup. A common feature of experimentally charact-
erized representatives is the presence of the K-D-K
catalytic triad and the ability to catalyze 20-O-ribose
methylation in RNA. A group of uncharacterized
proteins from fungi, which are closely related to hMTr1
and hMTr2 (Supplementary Figure S2), were excluded
because they lacked the K-D-K triad (data not shown),
indicating a change in substrate speciﬁcity or inactivity as
enzymes.
The minimal evolution phylogenetic tree (Figure 6)
revealed that hMTr1 and hMTr2 were paralogs forming a
subfamily with higher eukaryotic and viral members. The
hMTr1 orthologs were present in metazoans and various
lower eukaryotes. The remaining unicellular eukaryotes,
including stramenopiles (Thalassiosira pseudonana and
Phaeodactylum tricornutum), kinetoplastida (Trypanosoma
and Leishmania), alveolata (Toxoplasma gondii and
Perkinsus marinus, but not Plasmodium, Cryptosporidium
or Theileria species), diplomonadida (Giardia lamblia and
G. intestinalis), possessed a variant without the GTase-like
domain. The trypanosome ortholog of hMTr1 that lacked
the GTase-like domain exhibits cap1-MTase activity on
spliced leader RNA and U1 snRNA (26,41), indicating
that the C-terminal domain is not essential for the enzymatic
activity. Interestingly, several species such as mosquitos
Aedes aegypti and Culex quinquefasciatus possessed not
one but two orthologs of hMTr1, products of a lineage-
speciﬁc duplication. The Neodiprion sertifer nucleopoly-
hedrovirus (NsNPV) hMTr1 ortholog position was
Figure 5. Both hMTr1 and hMTr2 have a nuclear presence. MCF7 cells were transfected with GW1-myc-hMTr1, GW1-myc-hMTr2 or EGFP-C1
(control plasmid). After 24h, cells were ﬁxed and stained with anti-myc or anti-GFP antibodies to visualize recombinant proteins (green). Nuclei
were visualized with Hoechst 33258 staining (blue) and F-actin with phalloidin 568 (red). Images were acquired by confocal microscopy. (A) Single
focal planes from the Z-stack at nucleus level are presented. (B) Cells transfected with GW1-myc-hMTr2 with respective orthogonal axis view to
verify the labeling.
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otic cell to the virus, as postulated previously [(26), Figure 6
and Supplementary Figure S7]. This enzyme is distinct from
another large group of AcNPVcap1-MTase orthologs (40)
that formed a separate branch at the base of the clade
comprising both human cap MTases.
hMTr2 orthologs are present in metazoa as well as in
some other eukaryotic taxons. Several alvaeolata pos-
sessed only hMTr2 orthologs (e.g. Plasmodium,
Cryptosporidium and Theileria species), while Perkinus
marinus contained two hMTr2 orthologs in addition to a
hMTr1 ortholog, demonstrating that the number of
hMTr1/hMTr2 family members can vary in different
species of the same phylum. The hMTr2 orthologs were
found in the unicellular eukaryotes Monosiga brevicollis,a
choanoﬂagellate, and the green alga Chlamydomonas
reinhardtii, both of which lacked hMTr1 orthologs.
hMTr2 orthologs were present in dsDNA viruses, but
limited to African swine fever virus, which formed an
outgroup, and in Mimivirus, which was positioned
among eukaryotic proteins. Mimivirus likely acquired its
hMTr2 ortholog from a unicellular host, similar to the
acquisition of the trifunctional capping enzyme
comprising the TPase/GTase/cap0 MTase activities (15).
A separate branch with two groups was formed by two
other families of RNA cap MTase with predominantly
viral membership. One group was formed exclusively
due to the presence of a bifunctional cap0/cap1 MTase
domain found in ﬂaviviral multidomain proteins, while
the other comprised cap1 MTases from poxviruses, e.g.
cap1 MTase from vaccinia virus (VP39) that also serves
as a poly(A) polymerase stimulatory factor (45), as well as
the trypanosome cap2 and cap3/cap4 MTases
(27,28,46,47). The branch with the trypanosome cap2
MTase enzyme TbMTr2 contained members from other
unicellular eukaryotes, including Naegleria gruberi
(Heterolobosea), Paramecium tetraurelia and P. marinus
(alveolata) and M. brevicollis (choanoﬂagellida). Hence,
M. brevicollis had orthologs of both the hMTr2 and
TbMTr2 cap2 MTases, while lacking a detectable
ortholog of any known cap1 MTase, and P. marinus pos-
sessed as many as four orthologs of cap 20-O-ribose
MTases, including one, one, and two orthologs of
hMTr1, TbMTr2, and hMTr2, respectively (Figure 6
and Supplementary Figure S7).
DISCUSSION
Here, we identify the human HMTR2 gene (formerly
known as FTSJD1) that encodes cap2 MTase hMTr2
and characterize it in combination with the HMTR1-
encoded cap1-MTase hMTr1 (32). The hMTr2 can methy-
late RNA with both m
7GpppN and GpppN structures,
unlike the kinetoplastid TbMTr2 (27,47). The hMTr2 is
less efﬁcient for RNA without cap1, whereas TbMTr2
shows no preference (47). hMTr1 is capable of modifying
RNA that has the second transcribed nucleotide
methylated (cap02-RNA and capG2-RNA) with the
Figure 6. 20-O-ribose cap MTases change their speciﬁcity in the course of the evolution. A minimum evolution tree of homologs of known
20-O-ribose mRNA cap MTases is shown. The RrmJ family of 20-O-ribose MTases that act on rRNA (together with their close homologs Mrm2,
Trm7 and SpbJ) was used as an outgroup. Branches comprising multiple sequences from the same taxon have been collapsed and are illustrated as
triangles marked by the name of the taxon and an experimentally characterized representative. Bootstrap values for nodes are shown.
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as does VMT. hMTr1, like VMT and TbMTr1 (41),
methylates both capG-RNA and cap0-RNA (21,32).
hMTr1 shows no position 1 preference, as it can methylate
A, C and G residues with the similar effectiveness (21). In
contrast, TbMTr1 requires an A at position 1 with add-
itional downstream nucleotides shared on both the spliced
leader RNA and U1 snRNA (41). This discrepancy
between their speciﬁcities reﬂects biological function, as
the human enzyme methylates many diverse mRNA and
snRNA molecules, whereas in Trypanosoma substrates are
essentially homogeneous. No speciﬁc order of steps in cap
structure formation relative to Tgs1, hMTr1 and hMTr2
action was suggested. Cellular localization of hMTr1 is
nuclear, and hMTr2 is present in the cytoplasm and the
nucleus. Both were excluded from DNA-free nuclear
bodies that are likely to represent nucleoli, as opposed
to TbMTr1 that has nucleolar localization and forms a
complex with the SLA1 H/ACA snoRNP (48).
In humans, cap0 and cap1 methylations are present in
all mRNAs. Diversity in cap structure is introduced by
hMTr2 with about half of the capped poly(A) molecules
containing a 20-O-ribose methylated residue on the second
transcribed nucleotide (22). Cap2 methylation may target
mRNA for enhanced translation. Accordingly, kinetic
studies found 3-fold more cap012-modiﬁed mRNA in
the polysomal fraction as compared with unbound
mRNA in mouse L cells, whereas the amount of cap01-
modiﬁed RNA is similar in both fractions (49). Thus
cap012-modiﬁed mRNA may have an increased afﬁnity
for ribosomes; alternatively, methylation of cap2 could
occur after the mRNAs are loaded with ribosomes. An
increase in mRNA stability may be another byproduct
of cap methylation, as cap012-modiﬁed RNAs dominate
among more stable mRNAs (49). The two mechanisms
may act together or, depending on the sequence context,
be characteristic for some mRNA classes. An important
question to address is how some subclasses of mRNA are
distinguished from others by the capping machinery for
modiﬁcation by additional methylation. For TbMTr1, the
RNA sequence is the determinant of enzyme activity;
this enzyme acts with substrate speciﬁcity that favors the
spliced leader 50 sequence (26). hMTr1 does not discrim-
inate in vitro between substrates with different nucleotides
at the N1 position. The hMTr2 speciﬁcity may be dictated
by the sequence and/or structure of the substrate, and thus
be limited to certain sequence classes. No consensus target
sequence for cap2 methylation emerges from the studies of
mRNAs from mammalian cells (22,49,50). Further work
is required to elucidate the RNA features that direct
hMTr2 activity as well as the effect of cap2 on gene
expression.
The order of capping reactions may impact gene expres-
sion. The mRNA:guanine-N
7 (cap0) MTase and hMTr1
are nuclear enzymes (11,42). Creation of cap0-RNA
occurs co-transcriptionally (12,13). The hMTr1 interacts
with the C-terminal domain of RNA polymerase II (42),
which suggests that methylation of the ﬁrst transcribed
nucleotide also takes place during transcription. Human
cap0 MTase and hMTr1 act effectively on both
non-methylated and monomethylated RNA, which does
not support any speciﬁc order of action for these two
enzymes. hMTr2 probably acts on cap01-RNA in vivo.
This is supported by its substrate preference as it acts
the most efﬁciently on cap01-RNA. hMTr2 is present
both in the nucleus and cytoplasm, nevertheless its
activity was found almost exclusively in cytoplasm with
<5% of the cap2-MTase activity recovered in the nuclear
fraction (21). This may suggest that the nuclear form is
inactive and needs activation upon delivery to cytoplasm.
Another explanation of those results is that
overexpression of hMTr2 enhances its nuclear presence
that may be predominantly cytoplasmic for the native
protein. The TMG structure does not disturb the
activity of hMTr enzymes, and the fully methylated
capTMG12 structure can be formed in vitro in different
ways, suggesting that the order of reactions in the cap
formation pathway is determined by compartmentaliza-
tion in the cell and the transport of RNAs between differ-
ent cellular compartments during maturation, rather than
by speciﬁc substrate requirements.
The genes encoding the human enzymes responsible for
RNA 50 cap 20-O-ribose methylations appear to have
evolved from a common ancestor present during the radi-
ation of Eukaryota. The ancestral family from which the
ancient metazoan 50 cap 20-O-ribose MTase most likely
originated is the RrmJ family of ribose MTases, which
includes bacterial rRNA-modifying enzymes and eukary-
otic rRNA and tRNA-modifying enzymes, whose repre-
sentative was present in the Last Universal Common
Ancestor of extant organisms. The paralogous relation-
ship of the hMTr1 and hMTr2 families implies that
cap2-MTase activity in metazoans is the product of a
cap1-MTase-encoding gene duplication. hMTr2 evolved
independently of the TbMTr2 (cap2) MTase from tryp-
anosomes (27). The phylogenetic trees indicate independ-
ent transfers of cap MTases from different families
between unicellular eukaryotes and unrelated viruses,
including those with DNA or RNA genomes. Thus,
viruses played an important role in horizontal transmis-
sion of members of this family. In particular, the branches
of viral MTases appear as outgroups of eukaryotic
proteins, suggesting that metazoan, and consequently
human, cap 20-O-ribose MTases have a viral origin.
In addition to horizontal gene transfer, frequent dupli-
cation and gene loss events shaped the evolution of cap
20-O-ribose MTases. As a consequence, these proteins can
vary greatly in number even in closely related organisms.
A question arises regarding the speciﬁcity of these
enzymes along with the resulting 50 cap structure in their
hosts. The eukaryotes and viruses that possess only one
(or more) hMTr2 ortholog(s), but no hMTr1 ortholog,
suggest several scenarios. First, hMTr2 can act without
preceding methylation by hMTr1, hence capped RNAs
in some organisms and viruses may have cap02 (double
methylation) or even capG2 (single methylation). The cap
structures in RNAs from species that lack the hMTr1
ortholog are worth experimental examination. The
second possibility is that the ‘missing’ cap1 activity may
be provided by a 20-O-ribose MTase from yet another
family that remains to be discovered or groups with
proteins of other speciﬁcities. The 20-O-ribose methylation
4766 Nucleic Acids Research, 2011,Vol.39, No. 11activity has evolved independently several times (31,51,52)
and many members of other 20-O-ribose MTase families
(e.g. proteins from the completely unrelated SPOUTsuper-
family) remain to be characterized functionally. In organ-
isms, such as P. marinus that possess multiple orthologs
of one human enzyme with one activity, these proteins
may have evolved toward distinct speciﬁcities. A third
plausible explanation is that some of the hMTr2 orthologs
are capable of both cap1 and cap2 methylation. No enzyme
with such activity has been reported; however, there
are many examples of MTases that modify two or more
nucleosides in their substrates, including the bifunctional
cap0/cap1 MTase domain from ﬂaviviruses (53).
One striking difference between hMTr1 and hMTr2 is
the C-terminal fusion of the catalytic MTase domain with
an apparently inactivated variant of either a GTase or a
MTase domain, respectively. It appears that the
GTase-like domain is not important for the hMTr1
activity, while the MTase-like domain is essential for
hMTr2. We hypothesize that it may be involved in sub-
strate binding rather than directly in catalysis, in analogy
to the rRNA MTase RsmC, which also contains two
RFM domains: one involved in catalysis and the other
in RNA binding (54). We plan to address the role of in-
dividual domains in the hMTr2 activity in future studies.
Our understanding of the role of the 20-O-ribose methy-
lations in the cap structure is still incomplete. Impact on
translation rates and spliceosomal assembly have been
demonstrated, but little is known about the mechanisms.
The increase of translation rate by 20-O-ribose methyla-
tions in Xenopus (5,55), together with the fact that mRNA
molecules are undermethylated at position 2 in vivo
suggests that the pattern of cap 20-O-ribose methylation
by hMTr2 may be a key point of translation regulation.
The identiﬁcation of the gene-encoding hMTr2 in humans
and characterization of the enzyme provides a stepping
stone toward the understanding of 20-O-ribose methyla-
tion of RNAs in gene expression and mRNA splicing.
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